Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;37(12):988-990.
doi: 10.1016/j.urolonc.2019.08.002. Epub 2019 Sep 12.

Definitive and sustained increase in prostate cancer metastases in the United States

Neal A Patel  1 , Art Sedrakyan  2 , Fernando Bianco  3 , Ruth Etzioni  4 , Michael A Gorin  5 , Wei-Chun Hsu  2 , Jialin Mao  2 , Paul L Nguyen  6 , Edward Schaeffer  7 , Jonathan Shoag  1 , Andrew Vickers  8 , Jim C Hu  9
Affiliations

Definitive and sustained increase in prostate cancer metastases in the United States

Neal A Patel et al. Urol Oncol. 2019 Dec.

Erratum in

Abstract

Introduction: We examined the most recent Surveillance, Epidemiology, and End Results release to corroborate temporal trends in nonmetastatic and distant prostate cancer metastases in the United States.

Methods: Surveillance, Epidemiology, and End Results was analyzed for the incidence of nonmetastatic and distant metastasis for men with prostate cancer aged 50-74 and ≥75 years during 2004-2015. Incidence ratios (IR) were calculated relative to the year prior.

Results: The incidence of distant metastasis significantly increased from 451.0 to 504.0 per million (IR:1.12, 95% CI:1.01-1.24) from 2011 to 2012 and 532.3 to 586.1 per million (IR:1.10, 95% CI:1.00-1.21) from 2014 to 2015 in men aged ≥75 years. The incidence of distant metastasis did not significantly increase in men aged 55-74 over the study period.

Conclusion: We demonstrate a sustained and definitive increase in prostate cancer distant metastases in men aged ≥75 years. Although our observational study design cannot pinpoint the exact cause of this increase, which is likely multifactorial, this shift reverses declines in metastases at diagnoses that followed the advent of prostate-specific antigen screening.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Standardized prostate cancer incidence of non-metastatic and distant metastases by quarter during 2004 to 2015.
See this image and copyright information in PMC

References

    1. Welch HG and Albertsen PC: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009; 101: 1325–1329. - PMC - PubMed
    1. National Cancer Institute Surveillance, Epidemiology, and End Results program http://seer.cancer.gov/., accessed June 30 2019.
    1. Hu JC, Nguyen P, Mao J, et al.: Increase in prostate cancer distant metastases at diagnosis in the united states. JAMA Oncology 2017; 3: 705–707. - PMC - PubMed
    1. Thomas CR and Shyr Y: Determining Penetration of Prostate-Specific Antigen Screening Recommendations. JAMA Oncology 2017; 3: 707. - PubMed
    1. Jemal A, Ma J, Siegel R, et al.: Prostate cancer incidence rates 2 years after the US preventive services task force recommendations against screening. JAMA Oncology 2016; 2: 1657–1660. - PubMed